Cover Image
Market Research Report
Product code 
1001407

Asia Pacific Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Product, Application

Published: | The Insight Partners | 113 Pages | Delivery time: 1-2 business days

Price

Back to Top
Asia Pacific Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type, Product, Application
Published: March 17, 2021
The Insight Partners
Content info: 113 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The Asia Pacific cell line development market is expected to reach US$ 2,828.53million in 2027 from US$ 993.09million in 2019. The market is estimated to grow with a CAGR of 14.1% from 2020-2027.

The market growth is primarily driven by the increasing government participation in the cell line development projects and an upsurge in the development of the biotechnology industry. However, the susceptibility of cell lines toward contamination by various microorganisms hinders the market growth.

The Chinese government recognizes the country's potential in sustainable development, leading to leadership in the global biotechnology industry; therefore, it offers financial and regulatory assistance to predominantly support the research, development, and innovation strategies adopted by various companies. China has ~35 stem cell clinic research programs registered with the National Health Commission and the National Medical Products Administration. Along with various strategic industrial planning, the Chinese government is targeted development in recent years, particularly within the domestic biomedical sector, through strategic planning and research funding. In 2018, the Ministry of Science and Technology released the 2019 Annual Project Application Guide for Stem Cell and Transformation Research project. The government projected financing US$ 58 million (400 million Yuan) to support stem cell research. Two of the 22 nationally funded stem cell clinical research projects are correlated to c-kit cells.

Further, the government of South Korea has invested a substantial amount in the launch of various projects. According to an article published in Business Korea in August 2018, the government ministries-including the Ministry of Health and Welfare (MOHW); Ministry of Science and ICT (MSIT); and Ministry of Trade, Industry, and Energy (MOTIE)-were looking forward to launching a project named as National New Drug Development Support Project. It has invested ~US$ 1.78 billion (KRW 2 trillion) in this project. Hence, such high government investments drive the cell line development market growth in Asia Pacific countries.

The COVID-19 pandemic, leading to uncertainties around economic recovery, has affected the growth of the pharmaceutical industry in Asia Pacific. Cell lines are widely used in the development of various pharmaceuticals and biologics, as well as in applications such as drug screening, cell-based assay development, functional gene studies, diagnostics, and tissue engineering. Cell line development is crucial for examining the efficiency and toxicity of drugs in vitro. It reduces time, effort and cost, and minimizes the chance of drug failure in the clinical trial stage that involves the production of recombinant proteins such as monoclonal antibodies, growth factors, enzymes, and the novel approach of developing immunotherapy to treat cancer using a wide variety of expression systems. In the last few years, the collaboration between cell line developers or manufacturers and novel therapeutics companies has boosted the expansion of the cell-line development market. However, the pandemic has gathered the major attention toward the drug and vaccine development against the novel coronavirus, leading to the temporary suspension of other research activities.

On the basis of type, the North America cell line development market is segmented into primary cell lines, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell line segments held the largest market share in 2019, whereas the hybridomas segment is anticipated to register the highest CAGR in the market during the forecast period. The North America cell line development market, by product, is segmented into equipment, and media and reagents. The media & reagent segment held a larger share of the market in 2019, and it is anticipated to register a higher CAGR in the market from 2020 to 2027. Based on application, the North America cell line development market is segmented into drug discovery, bioproduction, and tissue engineering. The bioproduction segment held the largest market share in 2019. However, the drug discovery segment is anticipated to register the highest CAGR in the market during 2020-2027.

The Chinese Academy of Sciences (CAS) and National Stem Cell Foundation of Australia (NSCFA) are among the primary and secondary sources referred to while preparing the report on the Asia Pacific cell line development market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific cell line development market market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table of Contents
Product Code: TIPRE00009031

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Cell line development Market - By Type
    • 1.3.2 Cell line development Market - By Product
    • 1.3.3 Cell line development Market - By Application
    • 1.3.4 Asia PacificCell line development Market - By Country

2. Asia Pacific Cell Line Development Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia PacificCell Line Development Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Cell Line Development Market- Asia Pacific PEST Analysis
  • 4.3 Expert Opinion

5. Asia PacificCell Line Development Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 High Growth in Investments from the Government in Development of Cell Line
    • 5.1.2 Rising Development of the Biotechnology Sector
  • 5.2 Market Restraints
    • 5.2.1 Multiple Challenges in Cell Line Development
  • 5.3 Market Opportunity
    • 5.3.1 Increasing Stem Cell Research Regarding Cell Line Development Market
  • 5.4 Future Trend
    • 5.4.1 GrowingCompany Participation in the Cell Line Development Market
  • 5.5 Impact Analysis

6. Cell Line Development Market - Asia Pacific Analysis

  • 6.1 Asia PacificCell Line Development Market Revenue Forecasts and Analysis

7. Asia PacificCell Line Development Market Analysis and Forecasts To 2027 - ByType

  • 7.1 Overview
  • 7.2 Cell Line Development Market, by Type, 2019& 2027 (% Share)
  • 7.3 Primary Cell Line
    • 7.3.1 Overview
    • 7.3.2 Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.4 Hybridomas
    • 7.4.1 Overview
    • 7.4.2 Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.5 Continuous Cell Lines
    • 7.5.1 Overview
    • 7.5.2 Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
  • 7.6 Recombinant Cell Line
    • 7.6.1 Overview
    • 7.6.2 Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)

8. Asia Pacific Cell Line Development Market Analysis and Forecasts To 2027 - ByProduct

  • 8.1 Overview
  • 8.2 Cell Line Development Market, by Product, 2019& 2027 (% Share)
  • 8.3 Equipment
    • 8.3.1 Overview
    • 8.3.2 Equipment Market Revenue and Forecast to 2027 (US$ Mn)
  • 8.4 Media and Reagent
    • 8.4.1 Overview
    • 8.4.2 Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)

9. Asia PacificCell Line Development Market Analysis - ByApplication

  • 9.1 Overview
  • 9.2 Cell Line Development Market Share by Application 2019& 2027 (%)
  • 9.3 Drug Discovery
    • 9.3.1 Overview
    • 9.3.2 Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.4 Bioproduction
    • 9.4.1 Overview
    • 9.4.2 Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
  • 9.5 Tissue Engineering
    • 9.5.1 Overview
    • 9.5.2 Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)

10. Cell Line Development Market Revenue and Forecasts To 2027 - Geographical Analysis

  • 10.1 Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
    • 10.1.3 Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
    • 10.1.4 Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
    • 10.1.5 Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.6 Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
    • 10.1.7 China
      • 10.1.7.1 China Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.7.2 China Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.7.3 China Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.7.4 China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.8 Japan
      • 10.1.8.1 Japan Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.8.2 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.8.3 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.8.4 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.9 India
      • 10.1.9.1 India Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.9.2 India Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.9.3 India Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.9.4 India Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.10 South Korea
      • 10.1.10.1 South Korea Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.10.2 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.10.3 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.10.4 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
    • 10.1.11 Australia
      • 10.1.11.1 Australia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
      • 10.1.11.2 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
      • 10.1.11.3 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
      • 10.1.11.4 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)

11. Impact of COVID-19 Pandemic on Asia PacificCell Line Development Market

  • 11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

  • 12.1 Merck KGaA
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Financial Overview
    • 12.1.4 Product Portfolio
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Thermo Fisher Scientific, Inc.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Financial Information
    • 12.2.4 Product /Services Portfolio
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 SELEXIS
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Financial Overview
    • 12.3.4 Product/Service Portfolio
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 WuXiAppTec
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Financial Overview
    • 12.4.4 Service Portfolio
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 General Electric
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Financial Overview
    • 12.5.4 Product Portfolio
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Lonza
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Financial Information
    • 12.6.4 Product Portfolio
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Corning Incorporated
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Financial Overview
    • 12.7.4 Product Portfolio
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of terms

List Of Tables

  • Table 1. Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 2. Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 3. Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 4. China Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 5. China Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 6. China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 7. Japan Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 8. Japan Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 9. Japan Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 10. India Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 11. India Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 12. India Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 13. South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 14. South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 15. South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 16. Australia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
  • Table 17. Australia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
  • Table 18. Australia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
  • Table 19. Glossary of Terms, Cell Line Development Market

List Of Figures

  • Figure 1. Cell Line DevelopmentMarket Segmentation
  • Figure 2. Asia PacificCell Line Development Market Overview
  • Figure 3. Media and ReagentSegment Held Largest Share of Product in Cell Line DevelopmentMarket
  • Figure 4. India is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 5. Cell Line Development Market - Asia Pacific PEST Analysis
  • Figure 6. Cell Line Development Market Impact Analysis of Driver and Restraints
  • Figure 7. Asia PacificCell Line Development Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 8. Cell Line Development Market, Type, 2019& 2027 (% Share)
  • Figure 9. Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 10. Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 11. Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 12. Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 13. Cell Line Development Market, By Product, 2019& 2027 (% Share)
  • Figure 14. Equipment Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 15. Media and ReagentMarket Revenue and Forecast to 2027 (US$ Mn)
  • Figure 16. Cell Line Development Market Share by Application 2019& 2027 (%)
  • Figure 17. Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 18. Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 19. Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
  • Figure 20. Asia Pacific Cell Line Development Market Revenue Overview, By Country (2019) (US$ Mn)
  • Figure 21. Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 22. Asia Pacific Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
  • Figure 23. China Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 24. Japan Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 25. India Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 26. South Korea Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 27. Australia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
  • Figure 28. Impact of COVID-19 Pandemic in Asia Pacific Country Markets